{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:28:39Z","timestamp":1779888519629,"version":"3.53.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1097\/01.fpc.0000182784.77630.48","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T06:44:53Z","timestamp":1264574693000},"page":"79-86","source":"Crossref","is-referenced-by-count":20,"title":["Study of the genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes"],"prefix":"10.1097","volume":"16","author":[{"given":"Jacqueline","family":"Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Komoroski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snezana","family":"Mirkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Yoder","family":"Graber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna Lee","family":"Fackenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin G.","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Ratain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Innocenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Strom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210212","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R2-2-20210212","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","article-title":"The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence","volume":"7","author":"Mackenzie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"R3-2-20210212","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","article-title":"Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man","volume":"269","author":"Bosma","year":"1994","journal-title":"J Biol Chem"},{"key":"R4-2-20210212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3030233","article-title":"Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation","volume":"303","author":"Senafi","year":"1994","journal-title":"Biochem J"},{"key":"R5-2-20210212","first-page":"2879","article-title":"Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man","volume":"85","author":"Findlay","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-2-20210212","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-0760(01)00062-0","article-title":"Isolation and characterization of the monkey UDP-glucuronosyltransferase cDNA clone monUGT1A01 active on bilirubin and estrogens","volume":"77","author":"Vallee","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R7-2-20210212","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1124\/dmd.31.9.1117","article-title":"Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases","volume":"31","author":"Kuuranne","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"R8-2-20210212","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI915","article-title":"Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes","volume":"101","author":"Iyer","year":"1998","journal-title":"J Clin Invest"},{"key":"R9-2-20210212","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/dmd.31.5.589","article-title":"Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1","volume":"31","author":"Watanabe","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"R10-2-20210212","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(25)13456-1","article-title":"Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol","volume":"43","author":"Ebner","year":"1993","journal-title":"Mol Pharmacol"},{"key":"R11-2-20210212","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0065-2571(95)00006-2","article-title":"Regulation of the human bilirubin UDP-glucuronosyltransferase gene","volume":"36","author":"Brierley","year":"1996","journal-title":"Adv Enzyme Regul"},{"key":"R12-2-20210212","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.510300205","article-title":"Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences","volume":"30","author":"Ritter","year":"1999","journal-title":"Hepatology"},{"key":"R13-2-20210212","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/dmd.32.1.140","article-title":"An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes","volume":"32","author":"Soars","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"R14-2-20210212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/B:MOLE.0000043582.35335.ff","article-title":"Stimulation of transcriptional expression of human UDP-glucuronosyltransferase 1A1 by dexamethasone","volume":"31","author":"Kanou","year":"2004","journal-title":"Mol Biol Rep"},{"key":"R15-2-20210212","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0090-9556(24)15189-6","article-title":"Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2","volume":"28","author":"Walle","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"R16-2-20210212","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/dmd.30.5.564","article-title":"Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements","volume":"30","author":"Walle","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"R17-2-20210212","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(96)91273-8","article-title":"Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome","volume":"347","author":"Monaghan","year":"1996","journal-title":"Lancet"},{"key":"R18-2-20210212","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-8278(02)00359-8","article-title":"Inherited disorders of bilirubin metabolism","volume":"38","author":"Bosma","year":"2003","journal-title":"J Hepatol"},{"key":"R19-2-20210212","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00008571-200212000-00006","article-title":"Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups","volume":"12","author":"Innocenti","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R20-2-20210212","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/bbrc.2002.6683","article-title":"Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia","volume":"292","author":"Sugatani","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"R21-2-20210212","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1373\/clinchem.2003.024174","article-title":"Haplotype structure of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and its relationship to serum total bilirubin concentration in a male Korean population","volume":"49","author":"Ki","year":"2003","journal-title":"Clin Chem"},{"key":"R22-2-20210212","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1200\/JCO.2004.07.173","article-title":"Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan","volume":"22","author":"Innocenti","year":"2004","journal-title":"J Clin Oncol"},{"key":"R23-2-20210212","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00439-004-1183-x","article-title":"Two linked polymorphic mutations (A (TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome","volume":"115","author":"Maruo","year":"2004","journal-title":"Hum Genet"},{"key":"R24-2-20210212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01213011-200505000-00004","article-title":"Haplotypes of variants in the UDP-glucurnosyltransferase 1A9 and 1A1 genes","volume":"15","author":"Innocenti","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"R25-2-20210212","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/dmd.104.001800","article-title":"Racial variability in haplotype frequencies of ugt1a1 and glucuronidation activity of a novel single nucleotide polymorphism 686C>T (P229L) found in an African-American","volume":"33","author":"Kaniwa","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"R26-2-20210212","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/jhep.2001.24172","article-title":"The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR","volume":"33","author":"Sugatani","year":"2001","journal-title":"Hepatology"},{"key":"R27-2-20210212","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.0630614100","article-title":"Induction of bilirubin clearance by the constitutive androstane receptor (CAR)","volume":"100","author":"Huang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R28-2-20210212","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1073\/pnas.0438010100","article-title":"Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor","volume":"100","author":"Xie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-2-20210212","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1074\/jbc.M300645200","article-title":"Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1","volume":"278","author":"Yueh","year":"2003","journal-title":"J Biol Chem"},{"key":"R30-2-20210212","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/dmd.32.3.340","article-title":"Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression","volume":"32","author":"Gardner-Stephen","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"R31-2-20210212","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bcp.2003.11.002","article-title":"The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics","volume":"67","author":"Sugatani","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"R32-2-20210212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/siny.2002.0098","article-title":"Pharmacological interventions for the treatment of neonatal jaundice","volume":"7","author":"Dennery","year":"2002","journal-title":"Semin Neonatol"},{"key":"R33-2-20210212","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/1389200033489424","article-title":"Human hepatocytes as a tool for studying toxicity and drug metabolism","volume":"4","author":"Gomez-Lechon","year":"2003","journal-title":"Curr Drug Metab"},{"key":"R34-2-20210212","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0076-6879(96)72044-X","article-title":"Use of human hepatocytes to study P450 gene induction","volume":"272","author":"Strom","year":"1996","journal-title":"Meth Enzymol"},{"key":"R35-2-20210212","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0009-9236(99)70078-0","article-title":"Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism","volume":"65","author":"Iyer","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"R36-2-20210212","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0090-9556(24)15238-5","article-title":"The use of human hepatocyte cultures to study the induction of cytochrome P-450","volume":"27","author":"Kostrubsky","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"R37-2-20210212","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1067\/mcp.2000.110215","article-title":"In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone","volume":"68","author":"McCune","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"R38-2-20210212","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0928-0987(01)00135-X","article-title":"Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation","volume":"13","author":"LeCluyse","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"R39-2-20210212","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0169-409X(96)00417-6","article-title":"The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man","volume":"22","author":"Maurel","year":"1996","journal-title":"Adv Drug Delivery Rev"},{"key":"R40-2-20210212","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-2125.1999.00081.x","article-title":"Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes","volume":"48","author":"Li","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"R41-2-20210212","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-199835050-00003","article-title":"Inhibition and induction of cytochrome P450 and the clinical implications","volume":"5","author":"Lin","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"R42-2-20210212","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/00498250110057341","article-title":"Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin","volume":"31","author":"Hanioka","year":"2001","journal-title":"Xenobiotica"},{"key":"R43-2-20210212","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/mol.62.3.608","article-title":"Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38)","volume":"62","author":"Gagne","year":"2002","journal-title":"Mol Pharmacol"},{"key":"R44-2-20210212","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1158\/1078-0432.CCR-05-0703","article-title":"Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes","volume":"11","author":"Yong","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R45-2-20210212","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1023\/A:1008438109725","article-title":"UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan","volume":"9","author":"Ando","year":"1998","journal-title":"Ann Oncol"},{"key":"R46-2-20210212","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.tpj.6500072","article-title":"UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity","volume":"2","author":"Iyer","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"R47-2-20210212","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/0091270004267159","article-title":"Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38","volume":"44","author":"Paoluzzi","year":"2004","journal-title":"J Clin Pharmacol"},{"issue":"18","key":"R48-2-20210212","first-page":"39S","article-title":"Safety issues in using complementary and alternative medicine","volume":"20","author":"Markman","year":"2002","journal-title":"J Clin Oncol"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.fpc.0000182784.77630.48","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:22:24Z","timestamp":1739751744000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200602000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fpc.0000182784.77630.48","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}